Unknown

Dataset Information

0

Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.


ABSTRACT: (1) Background: Biomarkers might play a significant role in predicting the clinical outcomes of patients with ovarian cancer. By analyzing lipid metabolism genes, future perspectives may be uncovered; (2) Methods: RNA-seq data for serous ovarian cancer were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. The non-negative matrix factorization package in programming language R was used to classify molecular subtypes of lipid metabolism genes and the limma package in R was performed for functional enrichment analysis. Through lasso regression, we constructed a multi-gene prognosis model; (3) Results: Two molecular subtypes were obtained and an 11-gene signature was constructed (PI3, RGS, ADORA3, CH25H, CCDC80, PTGER3, MATK, KLRB1, CCL19, CXCL9 and CXCL10). Our prognostic model shows a good independent prognostic ability in ovarian cancer. In a nomogram, the predictive efficiency was notably superior to that of traditional clinical features. Related to known models in ovarian cancer with a comparable amount of genes, ours has the highest concordance index; (4) Conclusions: We propose an 11-gene signature prognosis prediction model based on lipid metabolism genes in serous ovarian cancer.

SUBMITTER: Zheng M 

PROVIDER: S-EPMC7731240 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile.

Zheng Mingjun M   Mullikin Heather H   Hester Anna A   Czogalla Bastian B   Heidegger Helene H   Vilsmaier Theresa T   Vattai Aurelia A   Chelariu-Raicu Anca A   Jeschke Udo U   Trillsch Fabian F   Mahner Sven S   Kaltofen Till T  

International journal of molecular sciences 20201201 23


(1) Background: Biomarkers might play a significant role in predicting the clinical outcomes of patients with ovarian cancer. By analyzing lipid metabolism genes, future perspectives may be uncovered; (2) Methods: RNA-seq data for serous ovarian cancer were downloaded from The Cancer Genome Atlas and Gene Expression Omnibus databases. The non-negative matrix factorization package in programming language R was used to classify molecular subtypes of lipid metabolism genes and the limma package in  ...[more]

Similar Datasets

| S-EPMC7593419 | biostudies-literature
| S-EPMC10055736 | biostudies-literature
| S-EPMC5732699 | biostudies-literature
| S-EPMC7374965 | biostudies-literature
| S-EPMC4101829 | biostudies-other
| S-EPMC4858122 | biostudies-literature
2012-12-20 | GSE35783 | GEO
| S-EPMC4762194 | biostudies-literature
| S-EPMC6218776 | biostudies-literature
2012-12-20 | E-GEOD-35783 | biostudies-arrayexpress